|
Volumn 72, Issue 1, 1993, Pages 37-41
|
Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
a a a a a a |
Author keywords
chemotherapy; doxorubicin; fluorouracil; folinic acid; gastric cancer; methotrexate; outpatients
|
Indexed keywords
DOXORUBICIN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CARCINOMATOSIS;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
SEPSIS;
STOMACH CANCER;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HUMAN;
MALE;
METHOTREXATE;
MIDDLE AGE;
PROSPECTIVE STUDIES;
STOMACH NEOPLASMS;
|
EID: 0027217474
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P Document Type: Article |
Times cited : (729)
|
References (21)
|